ReutersDrug firm says it entered into agreement with Beximco PharmaceuticalsA pharmaceutical company in Pakistan plans to import the antiviral drug remdesivir, which has shown promise in treating coronavirus patients, from Bangladesh, it said in a stock exchange filing on Friday. "Searle Pharma is planning to import remdesivir in finished form (ready to use) to meet the country's urgent requirements," the company told the Pakistan Stock Exchange. Pakistan's tally of infections stands at 64,000, with 1,317 deaths, but authorities estimate the disease will not peak until June. Searle said the Bangladesh imports would ensure an immediate supply of the drug at an affordable price, helping to eliminate treatment delays by Pakistan's healthcare providers. Bangladesh is one of 47 countries that fall in this category.

Source: Dhaka Tribune May 29, 2020 11:03 UTC